The presence of active C1 (C-1) on peripheral human lymphocytes
- PMID: 99872
- DOI: 10.1111/j.1423-0410.1978.tb02922.x
The presence of active C1 (C-1) on peripheral human lymphocytes
Abstract
We have shown that the first component of complement C1 is present in an active form on the surface of washed human peripheral lymphocytes but not on platelets or erythrocytes. This active C1 (C-1) was detected by its ability to transfer to sensitized cells carrying C4, i.e., EAC4, forming EAC-1,4. Active C1 was also able to consume C4. Treatment of these lymphocytes with 0.02 M EDTA removed C-1. EDTA-treated lymphocytes were able to bind exogenous purified human C-1. Comparative studies with sentized erythrocytes (EA) and EDTA treated lymphocytes showed that although fewer molecules of exogenous C1 could bind to the EDTA-treated lymphocytes than to EA, the consumption of C4 by C-1 bound to lymphocytes was significantly higher than that observed with EAC-1. When lymphocytes obtained from 2 patients with chronic lymphocytic leukemia and hypocomplementemia were tested, the release of C1, the C4 consumption and the binding of C-1 to EDTA-treated cells were highly inefficient.
Similar articles
-
C1 and human platelets. Decrease in chronic lymphocyte leukemia. Effect of lymphocytes.Pathol Biol (Paris). 1975 Dec;23 suppl:33-6. Pathol Biol (Paris). 1975. PMID: 817252
-
Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.J Immunol. 1986 May 1;136(9):3378-83. J Immunol. 1986. PMID: 3485688
-
Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement--I. Effect on fluid phase C1 and on C1 bound to EA or to EAC4.Immunochemistry. 1976 Mar;13(3):251-5. doi: 10.1016/0019-2791(76)90223-8. Immunochemistry. 1976. PMID: 1278930 No abstract available.
-
Unique C1 inhibitor dysfunction in a kindred without angioedema. I. A mutant C1 INH that inhibits C1-s but not C1-r.J Immunol. 1994 Mar 15;152(6):3199-209. J Immunol. 1994. PMID: 8144914
-
Modulation of lymphocyte proliferative responses to mitogens and antigens by complement components C1, C4 and C2.J Clin Lab Immunol. 1982 Oct;9(1):39-47. J Clin Lab Immunol. 1982. PMID: 6983586
Cited by
-
Depressed classical complement pathway activities in chronic lymphocytic leukaemia.Clin Exp Immunol. 1985 Jun;60(3):489-95. Clin Exp Immunol. 1985. PMID: 4017286 Free PMC article.
-
Acquired C1 inhibitor deficiency in a case of lymphosarcoma of the spleen. Reversal of complement abnormalities after splenectomy.Clin Exp Immunol. 1979 Sep;37(3):523-31. Clin Exp Immunol. 1979. PMID: 583138 Free PMC article.
-
Relation of neutrophil alkaline phosphatase activity to Fc IgG receptor development in human blood and bone marrow.J Clin Pathol. 1982 Sep;35(9):967-71. doi: 10.1136/jcp.35.9.967. J Clin Pathol. 1982. PMID: 6956585 Free PMC article.
-
Characterization of C1 inhibitor binding to neutrophils.Immunology. 1991 May;73(1):95-101. Immunology. 1991. PMID: 2045131 Free PMC article.
-
Interaction of human platelets with particle-adherent aggregated IgG: description of the experimental system and role of C1q and monomeric IgG.Clin Exp Immunol. 1983 May;52(2):423-9. Clin Exp Immunol. 1983. PMID: 6602680 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous